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Context and justification
• Cameroon is a Central African country of limited
resources with about 16 M inhabitants in 10 administra-
tive regions
￿ Surface area: 475 000 km2
￿ Prevalence: 5,5% EDSIII 2004
￿ PNLS .... Decentralisation (CTA, CTAFF, UPEC)
￿ Representing about 1/4 of the total surface area of Cam-
eroon, the East Region is under populated, with a total
population of about 945 000 h. This gives a population
density of about 3 per km2. It has one CTA and 8 UPECS
of which only 5 are functional. At 8,6% it has the second
highest national prevalence rate of HIV in the Country.
￿ There are 14 landlocked health districts having as a dis-
tance unit, 100 km to undertake in about 4 to 6 hours
depending on the season, which leads to the most recur-
rent reason given by patients to justify their poor observ-
ance of treatment.
￿ Resolution: D.O.T initiative
Objectives
￿ Ameliorate the observance of patients on ARV who live
far from the care units and whom distance leads to poor
appointment observance and follow up of ARV and O.I.D
Methods
A - Role of sites
￿ Massive sensibilisation and screening for the recruit-
ment of HIV+ patients
￿ Choosing patients belonging to associations
￿ Collection of samples to be analyzed at the appropriate
CTA
￿ Transportation of patients eligible for ARVT to the CTA
for evaluation and inclusion in the study
￿ Weekly sharing of ARV and O.I.D
B - Role of the tutor CTA
￿ Receiving and analyzing samples for PTW
￿ Clinical evaluation of patients for eligibility and treat-
ment of ARV according to the national directives.
￿ Making available Hospital Unit of ARV and MIO
￿ Clinical and biological follow up every 6 months
￿ Collection and analysis of data
￿ Networking the CTA and these Hospital Unit for even-
tual problems
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Results
￿ All the peripheral patients on D.O.T did their two bi-
annual workups expected during the period of study.
￿ No patient on D.O.T missed his appointment for sup-
plies of ARV or drugs for prophylaxis of O.I
￿ No patient on D.O.T on ARVT had an O.I during the
period of the study
￿ Total weight gain of patient on D.O.T was between 5 to
15 kg.
Conclusion
￿ The global management of PLHIV is a team and harmo-
nious problem
￿ A permanent and active coaching can ameliorate the
success of ARVT for the PLHIV by reducing the multiple
difficulties they face, be they linked to:
￿ The patient himself and his surroundings
￿ The drugs,
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